Zobrazeno 1 - 10
of 94
pro vyhledávání: '"R Comis"'
Publikováno v:
Quality of Life Research. 10:1-14
Purpose: Objectives of this study were to obtain data from Eastern Cooperative Oncology Group (ECOG) oncologists regarding their views on quality of life (QOL) information; perform psychometric testing on the MD-QOL questionnaire, develop a model to
Autor:
D. Ihde, B. Souhami, R. Comis, A. Gregor, H. Hansen, B. Johnson, N. Murray, P. Postmus, P. Rocmans, N. Saijo, R. Stout, A. Turrisi, H. Wagner
Publikováno v:
Ihde, D, Souhami, B, Comis, R, Gregor, A, Hansen, H, Johnson, B, Murray, N, Postmus, P E, Saijo, N, Stout, R, Turrisi, A & Wagner, H 1997, ' Small cell lund cancer ', Lung Cancer, vol. 17, no. suppl.1, pp. S19-S21 . https://doi.org/10.1016/S0169-5002(97)00039-1
Lung Cancer, 17(suppl.1), S19-S21. Elsevier Ireland Ltd
Lung Cancer, 17(suppl.1), S19-S21. Elsevier Ireland Ltd
Publikováno v:
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 10(1)
Objectives of this study were to obtain data from Eastern Cooperative Oncology Group (ECOG) oncologists regarding their views on quality of life (QOL) information; perform psychometric testing on the MD-QOL questionnaire, develop a model to describe
Autor:
Kathleen R. Lamborn, Walter J. Curran, Victor A. Levin, R. Comis, Kevin Murray, Theodore L. Phillips, Sucha O. Asbell, Richard L. Davis, P. Rubin, Charles Scott, Michael D. Prados, J S Nelson, M. Rotman, William T. Sause
Publikováno v:
International journal of radiation oncology, biology, physics. 40(3)
Purpose: To examine the effect treatment using Bromodeoxyuridine (BrdU) during radiation therapy on malignant glioma patient survival by comparing historical survival data from several large clinical trials. Methods: A retrospective analysis of patie
Publikováno v:
Seminars in oncology. 22(3 Suppl 6)
Based on the superior response rates (21% to 24%) of patients treated with single-agent paclitaxel (Taxol; Bristol-Myers Squibb Company, Princeton, NJ) in Eastern Cooperative Oncology Group and M.D. Anderson Cancer Center trials in non-small cell lun
Autor:
K. Dahlquist, Katherine Sharpe, K. Naples, M. Jin, R. Comis, L. Tis, Ted Gansler, James L. Kepner, Y. Hao, G. Cressman
Publikováno v:
Journal of Clinical Oncology. 27:e17504-e17504
e17504 Methods: Data from CTMS constituents and follow-up information describing enrollment status and barriers to trial participation are reviewed. Results: During 15 months of operation the CTMS provided information to 10,997 individuals; 7,521 (68
Publikováno v:
Journal of Clinical Oncology. 25:6626-6626
6626 Background: One reason for the low numbers of patients entered on cancer clinical trials is the difficulty and inconvenience encountered in determining whether patients are eligible. The introduction of electronic medical record (EMR) systems in
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Cancer treatment reports. 70(4)